Qube Research & Technologies LTD Bridge Bio Pharma, Inc. Transaction History

Qube Research & Technologies LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $63,643 - $94,127	2,327 Added 2216.19%	2,432 $75,000
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $2,522 - $4,608	105 New	105 $4,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $3.86 Million - $5.23 Million	-290,312 Reduced 84.45%	53,473 $919,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.46 Million - $3.77 Million	203,433 Added 144.94%	343,785 $5.7 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $171,175 - $292,573	25,397 Added 22.09%	140,352 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $912,742 - $1.42 Million	114,955 New	114,955 $1.14 Million
Q1 2022 May 09, 2022	SELL	$7.34 - $17.16 $124,251 - $290,484	-16,928 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$11.38 - $53.41 $192,640 - $904,124	16,928 New	16,928 $282,000
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $1.11 Million - $1.53 Million	-23,985 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $1.33 Million - $1.74 Million	23,985 New	23,985 $1.48 Million
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $242,331 - $448,988	-6,314 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $188,686 - $292,672	-6,937 Reduced 52.35%	6,314 $237,000
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $294,437 - $472,928	13,251 New	13,251 $432,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.